Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 1:37 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 409–432 of 2,608 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Application Use Clear all

Conditions: Diabetes Mellitus, Type 1
Interventions: Planet T1D; Behavioral
Lead sponsor: 3-C Institute for Social Development; Industry
Eligibility: 12 Years to 17 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Skin Cancer
Interventions: Electronic + no text message, Electronic monitor + text messages; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Low Back Pain, Mechanical, Acute Pain
Interventions: Emergency Department Digital Pain Self-Management Intervention (EDPSI), Routine Discharge Care; Behavioral · Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Vulvar Vestibulitis
Interventions: 5% topical lidocaine ointment, Placebo cream; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Dystonia
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2024
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Spinal Cord Injury
Interventions: A&L cycling, Body weight supported treadmill training (BWSTT); Device
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2032
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: ACL, Opioid Use, Cryotherapy Effect, Vibration; Exposure, Pain, Postoperative
Interventions: VibraCool mechanical stimulation and neuromodulatory therapeutic device, Cryocompression (Game Ready, Bregs) device, Standard ice packs; Device
Lead sponsor: Columbia University; Other
Eligibility: Not listed
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Pelvic Floor Myofascial Pain, Pelvic Pain, Myofascial Pain
Interventions: vaginal cryotherapy; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Malocclusion, Misaligned Teeth
Interventions: Clear Aligners with Dental Monitoring, Clear Aligners; Device
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 12 Years to 70 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2029
U.S. locations: 4
States / cities: Antioch, Illinois • Chicago, Illinois • Grayslake, Illinois + 1 more

Conditions: Open-angle Glaucoma (OAG), Ocular Hypertension (OHT), Glaucoma
Interventions: QLS-111, 0.015%, QLS-111, 0.030%, QLS-111, 0.075%, QLS-111 vehicle ophthalmic solution; Drug
Lead sponsor: Qlaris Bio, Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Radial Artery Spasm, Angina, Coronary Artery Disease
Interventions: Topical Nitroglycerine, Topical Lidocaine; Drug
Lead sponsor: Aultman Health Foundation; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Canton, Ohio

Conditions: Opioid Use Disorder, Injection Drug Use, Skin and Soft Tissue Infections (SSTIs)
Interventions: Chlorhexidine gluconate, Isopropyl Alcohol 70% Topical Application Solution, Skin Prep Before Injecting Recreational/Street Drugs; Drug · Behavioral
Lead sponsor: Gabriel John Culbert; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Type-1 Diabetes
Interventions: Eddii mobile application; Behavioral
Lead sponsor: Eddii, Inc.; Industry
Eligibility: 5 Years to 12 Years
Enrollment: 92 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Suspected Primary Prostate Cancer
Interventions: ProxiScan (scintigraphic rectal probe); Device
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years to 75 Years · Male only
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Gait, Unsteady
Interventions: Patients using Step Test Application and Accelerometer; Other
Lead sponsor: University of Chicago; Other
Eligibility: 60 Years and older
Enrollment: 100 participants
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Type 1 Diabetes Mellitus
Interventions: Decision Support System, Usual Care; Device · Other
Lead sponsor: Daniel Chernavvsky, MD; Other
Eligibility: 21 Years to 65 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Diabetes Mellitus in Pregnancy
Interventions: SweetMama Focus Groups, SweetMama Individual Testing, SweetMama Feasibility Testing - Pilot Randomized Trial; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Stress-induced Eating
Interventions: Meditation; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 943 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Dental Caries
Interventions: silver diamine fluoride, 38%, Sodium fluoride gel, 5000 PPM; Device
Lead sponsor: Texas A & M University Baylor College Of Dentistry; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Acne
Interventions: IDP-121 Lotion; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 9 Years to 17 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 2
States / cities: Austin, Texas • College Station, Texas

Conditions: Diabetes Mellitus, Type 1, Hypoglycemia
Interventions: Vigilant Diabetes Management Application; Device
Lead sponsor: InSpark Technologies, Inc.; Industry
Eligibility: 11 Years to 74 Years
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Bleeding
Interventions: TachoSil®, Surgicel® Original; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 37
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Long Beach, California + 25 more

Conditions: Central Line Associated Bloodstream Infections (CLABSI), Bone Marrow Transplant
Interventions: Parafilm; Device
Lead sponsor: Emory University; Other
Eligibility: Up to 21 Years
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Depression, Anxiety
Interventions: Woebot for Adolescents (W-GenZD) Mobile Application, CBT-Lite Teletherapy Group; Device · Behavioral
Lead sponsor: Woebot Health; Industry
Eligibility: 13 Years to 17 Years
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Norfolk, Virginia

Search by objective public record fields.

Mobile Technology & Online Tools to Track Adherence in Chronic Illness Patients

Evaluation of Adherence to Topical Agents: Applying Communication Technology to Improve Sunscreen Use

Emergency Department Digital Pain Self-Management Intervention to Improve Acute Low Back Pain Outcomes

5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis

Effect of Increasing Motor Cortex Inhibition on Task Specific Dystonia

Arm and Leg Cycling for Accelerated SCI Recovery

VibraCool Device to Reduce Pain and Opioid Use After Anterior Cruciate Ligament Reconstruction (ACLR)

Randomized Controlled Trial of Vaginal Cryotherapy for Pelvic Floor Myofascial Pain

Optimizing Orthodontic Appliances Efficiency With Remote Dental Monitoring and Artificial Intelligence Algorithms

Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients

Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention

A Pilot Study to Evaluate Skin Swabbing With Chlorhexidine to Prevent Skin And Soft Tissue Infections Among People Who Inject Drugs

Safety and Feasibility Study of the Eddii Mobile Application

Evaluation of a Transrectal Scintigraphic Detector(ProxiScanTM) for Detection of Primary Prostate Cancer

At-home Walking Cadence Functional Assessment and Recovery Trajectory for Older Adults Undergoing Major Surgery

Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM

SweetMama: Testing of a Novel Technology for Diabetes Education and Support to Pregnant Women

Guided Meditation and Stress-Induced Eating

SDF Application in Oral Cancer Patients to Prevent Dental Caries

Absorption and Systematic Pharmacokinetics of IDP-121 Lotion in Subjects With Acne Vulgaris

T1 Diabetes Hypoglycemia Prevention Pilot

Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery

Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCT

Feasibility and Acceptability of W-GenZD vs CBT-light Teletherapy for Adolescents Seeking Mental Health Services